Canadian cannabis company Organigram on Monday reported that its revenue soared by 503% to 19.23 million Canadian dollars ($14.5 million) in its fiscal fourth quarter, compared with CA$3.19 million in the same period a year ago. Organigram, which trades on the Nasdaq as OGI, experienced a net loss of CA$22.5 million compared with a profit of CA$18.1 million during its fiscal fourth quarter in 2018, which ended Aug. 31.
Source:
